C. Kneebone

发表

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

The clinical profile of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2020, Journal of Neurology.

A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.

N. Laing, S. Wilton, S. White, 1995, Nature genetics.

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

S. Broadley, J. Lechner-Scott, M. Slee, 2020, Frontiers in Neurology.

Unusual focal dyskinesias: The ears, the shoulders, the back, and the abdomen

P. Thompson, C. Marsden, J. Caviness, 1994, Movement disorders : official journal of the Movement Disorder Society.

Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy

M. Brown, P. Hissaria, C. Kneebone, 2017, Journal of Neuroimmunology.

The causes of sporadic and 'senile' chorea.

J. Warren, P. Thompson, P. Blumbergs, 1998, Australian and New Zealand journal of medicine.

A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy

E. Haan, N. Laing, S. Wilton, 1995, Nature Genetics.

Corrigendum: A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1

E. Haan, N. Laing, S. Wilton, 1995, Nature Genetics.

Erratum: A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1 (Nature Genetics (1995) 9 (75-79))

E. Haan, N. Laing, S. Wilton, 1995 .

Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis

A. Coulthard, S. Shakib, C. Kneebone, 2009, Multiple sclerosis.

The distinctive movement disorder of ovarian teratoma‐associated encephalitis

P. Thompson, A. Duggins, T. Kleinig, 2008, Movement disorders : official journal of the Movement Disorder Society.

Non-coding VMA21 deletions cause X-linked Myopathy with Excessive Autophagy

E. Haan, M. Mora, P. Blumbergs, 2015, Neuromuscular Disorders.

Chorea, transverse myelitis, neuropathy and a distinctive MRI: Paraneoplastic manifestations of probable small cell lung cancer

T. Kleinig, C. Kneebone, P. Thompson, 2009, Journal of Clinical Neuroscience.

Localized hypertrophic neuropathy: a case report and review of the literature.

P. Blumbergs, N. Jones, C. Kneebone, 2009, Clinical neuropathology.

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

S. Broadley, J. Lechner-Scott, M. Slee, 2021, Frontiers in Neurology.

RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy.

B. Shahani, D. Cros, C. Kneebone, 1990, Archives of neurology.

Incidence and prevalence of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Rendu-Osler-Weber syndrome: a current perspective on cerebral manifestations

C. Kneebone, B. Brophy, M. McDonald, 1998, Journal of Clinical Neuroscience.

A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1.

N. Laing, S. Wilton, S. White, 1995, Nature genetics.

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Alexander Parajeles Vindas, P. Kowey, D. Arnold, 2016, Neurology. Clinical practice.

Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I.

E. Haan, L. Kunkel, A. Beggs, 1992, American journal of human genetics.

The distinctive movement disorder of ovarian teratoma‐associated encephalitis

P. Thompson, A. Duggins, T. Kleinig, 2008, Movement disorders : official journal of the Movement Disorder Society.